{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:49:28Z","timestamp":1772120968265,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T00:00:00Z","timestamp":1767312000000},"content-version":"am","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100012833","name":"Niigata Daigaku","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012833","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","heartrhythmjournal.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.hrthm.2024.07.017","type":"journal-article","created":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T15:47:36Z","timestamp":1721058456000},"page":"21-28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Differences in coagulation responses to vascular injury between uninterrupted dabigatran and apixaban: A clinical prospective randomized study"],"prefix":"10.1016","volume":"22","author":[{"given":"Yasuhiro","family":"Ikami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0883-9279","authenticated-orcid":false,"given":"Daisuke","family":"Izumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Fujiki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotaka","family":"Sugiura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sou","family":"Otsuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naomasa","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuta","family":"Sakaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Hakamata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobue","family":"Yagihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Iijima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Ishizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaomi","family":"Chinushi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tohru","family":"Minamino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Inomata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrthm.2024.07.017_bib1","doi-asserted-by":"crossref","first-page":"448.e1","DOI":"10.1016\/j.amjmed.2005.10.057","article-title":"Quality of life in patients with atrial fibrillation: a systematic review","volume":"119","author":"Thrall","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.hrthm.2024.07.017_bib2","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1136\/jnnp.2004.048827","article-title":"Atrial fibrillation as a predictive factor for severe stroke and early death in 15,831 patients with acute ischaemic stroke","volume":"76","author":"Kimura","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.hrthm.2024.07.017_bib3","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/eurjhf\/hfp085","article-title":"A meta-analysis of the prognostic significance of atrial fibrillation in chronic heart failure","volume":"11","author":"Mamas","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.hrthm.2024.07.017_bib4","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/ejhf.187","article-title":"The prognostic significance of atrial fibrillation in heart failure with a preserved and reduced left ventricular function: insights from a meta-analysis","volume":"16","author":"Cheng","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.hrthm.2024.07.017_bib5","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1016\/j.jacc.2006.01.060","article-title":"Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure\u2013Assessment of Reduction in Mortality and morbidity (CHARM) program","volume":"47","author":"Olsson","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2024.07.017_bib6","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1093\/eurheartj\/ehn217","article-title":"New-onset atrial fibrillation is an independent predictor of in-hospital mortality in hospitalized heart failure patients: results of the EuroHeart Failure Survey","volume":"29","author":"Rivero-Ayerza","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2024.07.017_bib7","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1253\/circj.CJ-20-0637","article-title":"JCS\/JHRS 2019 Guideline on Non-Pharmacotherapy of Cardiac Arrhythmias","volume":"85","author":"Nogami","year":"2021","journal-title":"Circ J"},{"key":"10.1016\/j.hrthm.2024.07.017_bib8","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/europace\/eux274","article-title":"2017 HRS\/EHRA\/ECAS\/APHRS\/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation","volume":"20","author":"Calkins","year":"2018","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2024.07.017_bib9","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1253\/circj.CJ-20-1212","article-title":"JCS\/JHRS 2020 Guideline on pharmacotherapy of cardiac arrhythmias","volume":"86","author":"Ono","year":"2022","journal-title":"Circ J"},{"key":"10.1016\/j.hrthm.2024.07.017_bib10","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2024.07.017_bib11","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1093\/eurheartj\/ehy136","article-title":"The 2018 European Heart Rhythm Association Practical Guide on the use of non\u2013vitamin K antagonist oral anticoagulants in patients with atrial fibrillation","volume":"39","author":"Steffel","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2024.07.017_bib12","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1093\/eurheartj\/ehv177","article-title":"Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation","volume":"36","author":"Cappato","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2024.07.017_bib13","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1056\/NEJMoa1701005","article-title":"Uninterrupted dabigatran versus warfarin for ablation in atrial fibrillation","volume":"376","author":"Calkins","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2024.07.017_bib14","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1093\/eurheartj\/ehy176","article-title":"Apixaban in patients at risk of stroke undergoing atrial fibrillation ablation","volume":"39","author":"Kirchhof","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2024.07.017_bib15","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1093\/eurheartj\/ehz190","article-title":"Uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation: the ELIMINATE-AF trial","volume":"40","author":"Hohnloser","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2024.07.017_bib16","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","article-title":"Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation","volume":"285","author":"Gage","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2024.07.017_bib17","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.jacc.2012.02.008","article-title":"New oral anticoagulants in atrial fibrillation and acute coronary syndromes: ESC Working Group on Thrombosis\u2013Task Force on Anticoagulants in Heart Disease position paper","volume":"59","author":"De Caterina","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2024.07.017_bib18","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2215\/CJN.04920709","article-title":"Ultrasound-guided femoral dialysis access placement: a single-center randomized trial","volume":"5","author":"Prabhu","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.hrthm.2024.07.017_bib19","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.echo.2011.09.021","article-title":"Guidelines for performing ultrasound guided vascular cannulation: recommendations of the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists","volume":"24","author":"Troianos","year":"2011","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.hrthm.2024.07.017_bib20","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jacc.2017.10.076","article-title":"Effects of direct oral anticoagulants at the peak phase, trough phase, and after vascular injury","volume":"71","author":"Otuki","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2024.07.017_bib21","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jjcc.2014.07.021","article-title":"Clinical usefulness of measuring prothrombin time and soluble fibrin levels in Japanese patients with atrial fibrillation receiving rivaroxaban","volume":"65","author":"Nakano","year":"2015","journal-title":"J Cardiol"},{"key":"10.1016\/j.hrthm.2024.07.017_bib22","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jjcc.2014.08.006","article-title":"Impact of rivaroxaban compared with warfarin on the coagulation status in Japanese patients with non-valvular atrial fibrillation: a preliminary analysis of the prothrombin fragment 1+2 levels","volume":"65","author":"Tajiri","year":"2015","journal-title":"J Cardiol"},{"key":"10.1016\/j.hrthm.2024.07.017_bib23","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.hrthm.2019.10.015","article-title":"Prospective comparison of periprocedural coagulation markers among uninterrupted anticoagulants for atrial fibrillation ablation","volume":"17","author":"Nagao","year":"2020","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2024.07.017_bib24","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1161\/01.STR.30.12.2547","article-title":"Markers of thrombin and platelet activity in patients with atrial fibrillation: correlation with stroke among 1531 participants in the stroke prevention in atrial fibrillation III study","volume":"30","author":"Feinberg","year":"1999","journal-title":"Stroke"},{"key":"10.1016\/j.hrthm.2024.07.017_bib25","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s40256-018-0294-z","article-title":"Biomarkers of thrombosis in ST-segment elevation myocardial infarction: a substudy of the ATOLL trial comparing enoxaparin versus unfractionated heparin","volume":"18","author":"Silvain","year":"2018","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.hrthm.2024.07.017_bib26","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1055\/s-0043-1775856","article-title":"Thrombin generation markers as predictors of cancer-associated venous thromboembolism: a systematic review","volume":"50","author":"Gyldenholm","year":"2024","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.hrthm.2024.07.017_bib27","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1111\/j.1538-7836.2007.02753.x","article-title":"Three different patterns of calibrated automated thrombogram obtained with six different anticoagulants","volume":"5","author":"Samama","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.hrthm.2024.07.017_bib28","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1752-0509-4-5","article-title":"Blood flow controls coagulation onset via the positive feedback of factor VII activation by factor Xa","volume":"4","author":"Shibeko","year":"2010","journal-title":"BMC Syst Biol"},{"key":"10.1016\/j.hrthm.2024.07.017_bib29","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.bcmd.2005.12.034","article-title":"Models of blood coagulation","volume":"36","author":"Mann","year":"2006","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.hrthm.2024.07.017_bib30","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/ijlh.12235","article-title":"Interpretation of coagulation test results under direct oral anticoagulants","volume":"36","author":"Mani","year":"2014","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.hrthm.2024.07.017_bib31","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1182\/hematology.2021000241","article-title":"Direct oral anticoagulant (DOAC) interference in hemostasis assays","volume":"2021","author":"Moser","year":"2021","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.hrthm.2024.07.017_bib32","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2165\/00003088-200847050-00001","article-title":"Clinical pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor dabigatran etexilate","volume":"47","author":"Stangier","year":"2008","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.hrthm.2024.07.017_bib33","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/bcp.12106","article-title":"Safety, pharmacokinetics and pharmacodynamics of multiple oral doses of apixaban, a factor Xa inhibitor, in healthy subjects","volume":"76","author":"Frost","year":"2013","journal-title":"Br J Clin Pharmacol"}],"container-title":["Heart Rhythm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527124028984?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527124028984?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T04:01:22Z","timestamp":1735790482000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547527124028984"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1547527124028984"],"URL":"https:\/\/doi.org\/10.1016\/j.hrthm.2024.07.017","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.12.18.23300179","asserted-by":"object"}]},"ISSN":["1547-5271"],"issn-type":[{"value":"1547-5271","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differences in coagulation responses to vascular injury between uninterrupted dabigatran and apixaban: A clinical prospective randomized study","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrthm.2024.07.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Heart Rhythm Society. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}